Hypoglycemia in the diabetes control and complications trial

Diabetes

Volumn 46, Issue 2, 1997, Pages 271-286

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; COMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031006603     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.271     Document Type: Article

References (36)

1. The DCCT Research Group: The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Mühlhauser I, Berger M, Sonnenberg G, Koch J, Jörgens V, Schernthaner G, Scholz V, Pädagogin D: Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care 8:268-273, 1985
3. Goldstein DE, England JD, Hess R, Rawlings SS, Walker B: A prospective study of symptomatic hypoglycemia in young diabetic patients. Diabetes Care 4:601-604, 1981
4. Mecklenburg RS, Benson EA, Benson JW, Blumenstein BA, Fredlund PN, Guinn TS, Metz RJ, Nielsen RL: Acute complications associated with insulin infusion pump therapy: report of experience with 161 patients. JAMA 252:3265-3269, 1984
5. Goldgewicht C, Slama G, Papoz L, Tchobroutsky G: Hypoglycemic reactions in 172 type I (insulin-dependent) diabetic patients. Diabetalogia 24:95-99, 1983
6. The DCCT Research Group: Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 10:1-19, 1987
7. The DCCT Research Group: Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:450-459, 1991
8. Reichard P, Nilsson B-Y, Rosenquist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
9. The DCCT Research Group: Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 18:361-375, 1995
10. The DCCT Research Group: Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18:1415-1427, 1995
11. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
12. The DCCT Research Group: The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 45:1289-1298, 1996
13. The DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): design and methodological considerations for the feasibility phase. Diabetes 35:530-545, 1986
14. The DCCT Research Group: DCCT Manual of Operations. Springfield, VA, Department of Commerce, 1993 (National Technical Information Service, Publication No. 93-183382)
15. DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): update. Diabetes Care 13:427-433, 1990
16. Siebert C, Clark CM: Operational and policy considerations of data monitoring in clinical trials: Diabetes Control and Complications Trial experience. Control Clin Trials 14:30-44, 1992
17. Lee ET Statistical Methods for Survival Data Analysis. Belmont, CA, Lifetime Learning Publications, 1980, p. 88-92, 127-129, 306-312
18. McCulloch P, Neider JA: Generalized Linear Models. 2nd ed. New York, Chapman & Idall, 1989, p. 194-200, 429-430
19. Becker RA, Chambers JMS: An Interactive Environment for Data Analysis and Graphics. Belmont, CA, Wadsworth, 1984
20. Fleming TK, Harrington DP: Counting Processes and Survival Analysis. New York, Wiley, 1969
21. Breslow NE, Day NE: Statistical Methods in Cancer Research. Volume II: The Design and Analysis of Cohort Studies. Lyon, France, International Agency for Research on Cancer (London, Oxford University Press), 1987
22. Korn EL, Simon R: Explained residual variation, explained risk, and goodness of fit. The American Statistician 45:201-206, 1991
23. Cryer PE, Fisher JN, Shamoon H: Hypoglycemia Diabetes Care 17:734-755, 1994
24. Jorgens V, Gruber M, Bott U, Mulhauser I, Berger M: Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 36:99-105, 1993
25. Mühlhauser I, Bruckner I, Berger M, Cheta D, Jorgens V, Ianescu-Tirgoviste C, Sholz V, Mineu I: Evaluation of an intensified insulin treatment and teaching programme as routine management of type I diabetes. Diabetologia 30:681-690, 1987
26. Reichard P, Rosenquist U, Britz A: Intensified conventional insulin treatment and neuropsychological impairment. Br Med J 303:1439-1442, 1991
27. Wredling R, Levander S, Adamson U, Lins PE: Permanent neuropsychological impairment after recurrent episodes of severe hypoglycemia in man. Diabetologia 33:152-157, 1990
28. Hepburn DA, Patrick W, Eadington DW, Ewing DJ, Frier BM: Unawareness of hypoglycemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med 7:711-717, 1990
29. Davis MR, Shamoon H: Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Med 73:995-1001, 1991
30. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226, 1991
31. Widom B, Simonson DC: Intermittent hypoglycemia impairs glucose counterregulation. Diabetes 41:1597-1602, 1992
32. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689, 1993
33. Dagogo-Jack S, Rattarasarn C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434, 1994
34. Davis MR, Mellman M, Friedman S, Chang CJ, Shamoon H: Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. Am J Med 97:535-542, 1994
35. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, DiVincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Periello G, DeFeo P, Santensanio F, Brunetti P, Bolli GB: Long-term recovery from unawareness, deficient counterregulation, and lack of cognitive dysfunction during hypoglycemia following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37:1265-1276, 1994
36. Cranston I, Lomas J, Maran A, Macdonald I, Amiel S: Restoration of hypoglycemia awareness in patients with long duration insulin dependent diabetes. Lancet 344:283-287, 1994